The CBSE Class 11 2026 exam is expected to be conducted in February–March 2026 by the Central Board of Secondary Education ...

Q3 2025 Earnings Call Transcript November 4, 2025 Verastem, Inc. misses on earnings expectations. Reported EPS is $-1.35 EPS, ...

North Korean leader Kim Jong Un and U.S. President Donald Trump shake hands across the line that divides the two Koreas ...

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline ...

Experts say AI isn't wiping out all junior roles, but it's forcing fresh grads to level up and prove the one thing machines ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsLionel McBee - Vice President of Investor ...

Net Income was $14 million, an increase of $15 million year-over-year;Adjusted EBITDA* was $118 million, an increase of $2 million ...

Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsNathan Rozof - Head of Investor RelationsCameron Bready ...

Freshworks Inc. (Nasdaq: FRSH), the leading provider of uncomplicated software that delivers exceptional customer and employee experiences, today announced financial results for its third quarter ...

Third quarter performance driven by strong portfolio royalty revenue growth of 47%2025 full year revenue guidance increased to $225 million - ...

Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...